Comments

Opus Genetics Stock Price, Quotes and Forecasts

Q: What sector and industry does Opus Genetics (IRD) operate in?

Opus Genetics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

IRDNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$0.9940

-0.02-1.58%

At close: -

$1.01

0.021.61%

After Hours: 8:57 AM EDT

Q1 2025 Earnings were released on Thu May 15th, before the market open

Opus Genetics (IRD) Forecast

News Earnings Opus Genetics (IRD) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Opus Genetics Stock Price, Quotes and Forecasts | NASDAQ:IRD | Benzinga

Explore Opus Genetics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for IRD.

Open	$1.00
Close	$0.99
Volume / Avg.	153.57K / 215.26K
Day Range	$0.99 - $1.03
52 Wk Range	0.65 - 2.18
Market Cap	$60.26M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	55
Short Interest	0.18%
Days to Cover	1

Recent News

No news found

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Dec 24

Feb

Apr

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$1.00
Close	$0.99
Volume / Avg.	153.57K / 215.26K
Day Range	$0.99 - $1.03
52 Wk Range	0.65 - 2.18
Market Cap	$60.26M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	55
Short Interest	0.18%
Days to Cover	1

About Opus Genetics Inc.

Sector

Health Care

Industry

Biotechnology

Opus Genetics Inc is a clinical-stage ophthalmic biopharmaceutical company developing therapies to t...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Opus Genetics (IRD) stock?

You can purchase shares of Opus Genetics (NASDAQ:IRD) through any online brokerage.

View our list of the best stock brokerages

Who are Opus Genetics (IRD) competitors?

Other companies in Opus Genetics’s space includes: Zura Bio (NASDAQ:ZURA), Kalaris Therapeutics (NASDAQ:KLRS), Outlook Therapeutics (NASDAQ:OTLK), Serina Therapeutics (AMEX:SER) and Skye Bioscience (NASDAQ:SKYE).

What is the forecast, or price target, for Opus Genetics (IRD) stock?

Opus Genetics has a consensus price target of $7.33.

What is the current price for Opus Genetics (IRD)?

The stock price for Opus Genetics (NASDAQ: IRD) is $1.01 last updated May 20, 2025 at 8:57 AM EDT.

Does Opus Genetics (IRD) pay a dividend?

There are no upcoming dividends for Opus Genetics.

When is Opus Genetics (NASDAQ:IRD) reporting earnings?

Opus Genetics’s Q2 earnings are confirmed for Friday, August 15, 2025.

Is Opus Genetics (IRD) going to split?

There is no upcoming split for Opus Genetics.

What sector and industry does Opus Genetics (IRD) operate in?

Opus Genetics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.